3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
18
Phase 2
16
Phase NA
2
Phase 1/2
1
Status
Terminated
1
Completed
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Thoracic
7
Tumor-Agnostic
2
Gastrointestinal
2
Head & Neck
1
CNS
1
Breast
1
Conditions
Neoplasms
1
Neoplasm Metastasis
1
Interventions
Blood Specimen Collection
25
Standard of Care
23
Surveys and Questionnaires
18
Methods
14
Exercise
14
Educational Status
14
Interviews as Topic
13
Magnetic Resonance Spectroscopy
12
Biopsy
12
Radiosurgery
11
Palliative Care
10
Radiotherapy
9
Practice Guidelines as Topic
9
Early Intervention, Educational
9
Music Therapy
8
Therapeutics
7
Control Groups
7
Positron Emission Tomography Computed Tomography
6
Patient Navigation
5
Mindfulness
5
Fluorodeoxyglucose F18
5
Telemedicine
4
Geriatric Assessment
4
Decision Support Techniques
4
Counseling
4
Behavior Therapy
4
Art Therapy
4
Yoga
3
Sunitinib
3
Quality of Life
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase NA
×
Erlotinib Hydrochloride
×
Tumor-Agnostic
×
Clear all
NCT01636908
2021-04-15
ICK
Amsterdam UMC, location VUmc
Phase NA
Completed
43 enrolled
NCT01190241
2020-11-20
TSAP
Amsterdam UMC, location VUmc
Phase NA
Terminated
45 enrolled